← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2015Last known activity
Mar 22, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (22 distinct, 7 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06890143CollaboratorPhase 3Mar 22, 2025
- NCT06711679CollaboratorPhase 4May 10, 2024
- NCT05681260CollaboratorPhase 3Feb 6, 2023
- NCT05491304CollaboratorPhase 4Sep 1, 2022
- NCT06524596Lead sponsorN/AJan 1, 2022
- NCT06524596Sponsor investigatorN/AJan 1, 2022
- NCT07049172Lead sponsorN/AJan 1, 2021
- NCT07049172Sponsor investigatorN/AJan 1, 2021
- NCT03249480CollaboratorPhase 4Jan 31, 2015
Details
- Last known activity
- Mar 22, 2025